Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

Browse > Organization > American Academy of Neurology

NGC Browse - Organizations

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z List all

American Academy of Neurology


Check the box next to a guideline to add it to your Guideline Collection. Then click on the "Add to Guideline Collection" button located on the page.

Guidelines 1 to 20 of 51

  Title
  (1) Assessment: prevention of post-lumbar puncture headaches. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (2) Addendum to assessment: prevention of post-lumbar puncture headaches. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2000 Oct (revised 2005 Aug). Original guideline: 6 pages; Addendum: 3 pages. NGC:004514
  Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). American Academy of Neurology - Medical Specialty Society
American Stroke Association - Disease Specific Society. 2002 Jul (reviewed 2005 Oct). 10 pages. NGC:003146
  Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2008 Sep 2. 8 pages. NGC:006705
  Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2004 May 11. 14 pages. NGC:003644
  Assessment: use of epidural steroid injections to treat radicular lumbosacral pain. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2007 Mar 6. 7 pages. NGC:005580
  Carotid endarterectomy — an evidence-based review. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2005 Sep. 8 pages. NGC:004531
  Clinical utility of surface EMG: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2000 Jul (reviewed 2003). 7 pages. NGC:002054
  Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. American Academy of Neurology - Medical Specialty Society
Multiple Sclerosis Council - Disease Specific Society. 2002 Jan 22 (reviewed 2003 Oct). 10 pages. NGC:003144
  Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. American Academy of Neurology - Medical Specialty Society. 2004 Apr 27. 9 pages. NGC:003564
  Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. American Academy of Neurology - Medical Specialty Society. 2004 Apr 27. 13 pages. NGC:003565
  Evidence report: the medical treatment of ocular myasthenia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2007 Jun 12. 6 pages. NGC:005863
  Immunization and multiple sclerosis: a summary of published evidence and recommendations. American Academy of Neurology - Medical Specialty Society
Multiple Sclerosis Council - Disease Specific Society. 2002 Dec 24 (reviewed 2006 Dec). 7 pages. NGC:003148
  Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2007 Mar 27. 8 pages. NGC:005579
  Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. American Academy of Neurology - Medical Specialty Society
American Epilepsy Society - Disease Specific Society. 1999 May (reviewed 2006 Oct). 6 pages. NGC:002047
  Practice advisory: utility of surgical decompression for treatment of diabetic neuropathy. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2006 Jun. 4 pages. NGC:005159
  Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2000 May (reviewed 2003). 6 pages. NGC:002049
  Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2003 Jan 14. 7 pages. NGC:003149
  Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. American Academy of Neurology - Medical Specialty Society. 2005 Jan. 8 pages. NGC:004041
  Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2006 Apr 11. 8 pages. NGC:004935
  Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. American Academy of Neurology - Medical Specialty Society. 2001 May (reviewed 2004). 11 pages. NGC:002043


Search Help
Detailed Search
Frequent Searches